Jakob Dupont - Aug 17, 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
EVP, Head of R&D
Signature
/s/ Nimit Arora, Attorney-in-Fact for Jakob Dupont
Stock symbol
ATRA
Transactions as of
Aug 17, 2021
Transactions value $
-$26,969
Form type
4
Date filed
8/19/2021, 07:32 PM
Previous filing
May 20, 2021
Next filing
Nov 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$27K -2.15K -2.27% $12.53* 92.8K Aug 17, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 17, 2021 and August 18, 2021 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.